CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company’s stock is expected to be added to the Nasdaq Biotech Index (NASDAQ: NBI) as part of the annual reconstitution of the 2025 Nasdaq indexes. Lifecore’s inclusion in the Nasdaq Biotech Index will be effective prior to market open on Monday, December 22, 2025. T ...

Company Awarded Extension to Existing Supply Tender Relating to its Portfolio of Four Specialty Plasma-Derived ProductsSupply Extension Secures Ongoing Sales of Approximately $5.0-$7.0 Million Per Year for the Period Between Q2-26 and Q1-28Kamada Reiterates its 2025 Full-Year Revenue Guidance of $178 Million-$182 Million and Adjusted EBITDA of $40 Million-$44 MillionKamada Projects Double-Digit Growth in Revenues and Profitability in 2026; Detailed Guidance to be Provided in January 2026 REHOVOT, Israel, an ...

SEATTLE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that Thijs Spoor, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 14, 2026, at 2:15 p.m. PT. 44th Annual J.P. Morgan Healthcare Conference – Company PresentationDate: Wednes ...

Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment for which alternate treatment options are inadequate. Illicit fentanyl and its core precursor chemicals have been designated as weapons of mass destruction to enable the US government to combat the manufacture and distribution by cartels and foreign networks that have flooded the US with illegal fentanyl. Nut ...

VANCOUVER, BC, Dec. 18, 2025 /PRNewswire/ - OceanaGold Corporation (TSX: OGC) (OTCQX: OCANF) ("OceanaGold" or the "Company") is pleased to announce that the Expert Panel appointed by the New Zealand government to consider permitting of the Waihi North Project ("WNP") has released a final decision approving the project. OceanaGold is now officially permitted to develop and operate WNP, which includes the high-grade Wharekirauponga Underground mine ("WUG"), located ~10 kilometres ("km") North of the Company' ...

When Alex pulled into the garage after work two years ago, he didn’t expect a confession that would shake both his marriage and his family’s finances. His wife, Jackie, a 33-year-old stay-at-home mother of four in North Dakota, told him she had secretly spent between $5,000 and $6,000 on a Tony Robbins-branded coaching program to their savings without telling him. The purchase couldn’t be refunded, and she wasn’t sure what, exactly, it would deliver. Must Read “It hurt really bad,” Alex told Ramit Set ...

BRYN MAWR, Pa.--(BUSINESS WIRE)--Essential Utilities Inc. (NYSE: WTRG) today announced the successful results of its 2025-2026 United Way campaign and its fifth annual Fall for Food Banks initiative. The two company-wide efforts mobilized employees across its nine-state footprint, resulting in donations totaling $1,277,325 to support local communities facing food insecurity and other challenges. Through the United Way campaign, more than $755,000 was raised through individual pledges from emplo. ...

Compared to intravenous (IV) delivery, RYBREVANT FASPROâ"¢ significantly reduced administration time from several hours to approximately five minutes and demonstrated an approximately fivefold reduction in administration-related reactions (ARRs) (13 percent in SC vs 66 percent in IV arm). "Formulated with our leading ENHANZE drug delivery technology, RYBREVANT FASPROâ"¢ has the potential to make administration faster and more convenient for patients and their families compared to intravenous administration, ...

Q1 GAAP revenues of $607.6 million, up 6.9% from Q1 2025.Organic ASV was $2,389.6 million at November 30, 2025, up 5.9% year over year.Q1 GAAP operating margin of 31.6%, down approximately 200 bps year over year.Q1 adjusted operating margin of 36.2%, down 137 bps year over year.Q1 GAAP diluted EPS of $4.06, up 4.4% from the prior year, and Q1 adjusted diluted EPS of $4.51, up 3.2% year over year.FactSet's Board of Directors approved an increase to the existing share repurchase authorization from $400 millio ...

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Hercules Metals Corp. (TSXV: BIG) (OTCQB: BADEF) (FSE: C0X) ("Hercules" or the "Company") is pleased to announce the appointment of Mr. Matthieu Bos as an independent director of the Company and Chairman of the Board, effective immediately. Mr. Bos succeeds Peter Simeon, who will continue to serve as a director of the Company.Matthieu Bos is a mining executive and capital markets professional with more than 15 years of experience spanning investment ...